- Home
- CRDF vs PRCH Comparison
CRDF vs PRCH Comparison
Compare CRDF & PRCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- PRCH
- Stock Information
- Founded
- CRDF 1999
- PRCH 2012
- Country
- CRDF United States
- PRCH United States
- Employees
- CRDF N/A
- PRCH N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- PRCH Computer Software: Prepackaged Software
- Sector
- CRDF Health Care
- PRCH Technology
- Exchange
- CRDF Nasdaq
- PRCH Nasdaq
- Market Cap
- CRDF 143.4M
- PRCH 140.1M
- IPO Year
- CRDF N/A
- PRCH N/A
- Fundamental
- Price
- CRDF $2.58
- PRCH $2.98
- Analyst Decision
- CRDF Strong Buy
- PRCH Buy
- Analyst Count
- CRDF 3
- PRCH 7
- Target Price
- CRDF $9.33
- PRCH $4.18
- AVG Volume (30 Days)
- CRDF 1.1M
- PRCH 3.7M
- Earning Date
- CRDF 11-07-2024
- PRCH 11-07-2024
- Dividend Yield
- CRDF N/A
- PRCH N/A
- EPS Growth
- CRDF N/A
- PRCH N/A
- EPS
- CRDF N/A
- PRCH N/A
- Revenue
- CRDF $688,000.00
- PRCH $452,099,000.00
- Revenue This Year
- CRDF $15.00
- PRCH $8.67
- Revenue Next Year
- CRDF N/A
- PRCH $5.56
- P/E Ratio
- CRDF N/A
- PRCH N/A
- Revenue Growth
- CRDF 49.57
- PRCH 19.04
- 52 Week Low
- CRDF $1.07
- PRCH $1.05
- 52 Week High
- CRDF $6.42
- PRCH $4.78
- Technical
- Relative Strength Index (RSI)
- CRDF 41.24
- PRCH 61.39
- Support Level
- CRDF $2.85
- PRCH $2.82
- Resistance Level
- CRDF $4.38
- PRCH $3.85
- Average True Range (ATR)
- CRDF 0.45
- PRCH 0.41
- MACD
- CRDF -0.10
- PRCH 0.08
- Stochastic Oscillator
- CRDF 2.70
- PRCH 53.45
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About PRCH Porch Group Inc.
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions.